Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial of Early Initiation of CGM-Guided Insulin Therapy in Stage 2 T1D

NCT04335513 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT04335513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04335513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial of Early Initiation of CGM-Guided Insulin Therapy in Stage 2 T1D
Lead sponsor
University of Colorado, Denver
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2020
Completion date
July 31, 2023
Enrollment
84 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diabetes, dysglycemia, prediabetic state, type 1 diabetes